New TABAs technique in coronary bifurcation stenosis treatment
Abstract
Percutaneous coronary intervention (PCI) in coronary bifurcation stenosis is still regarded as technically complicated, due to the risk of lateral branch occlusion. Bifurcation stenosis is also characterised by higher intervention costs and restenosis incidence. Over the last 10 years, a range of new stenting techniques for coronary bifurcation stenosis treatment have been developed. These methods improved the rates of short-term PCI success, while drugeluting stents substantially reduced restenosis incidence. However, the limitations of existing methods make the intervention technically challenging and negatively affect long-term PCI results. This paper describes an original PCI method for bifurcation stenosis treatment, called TABAs.
About the Authors
T. A. Batyraliev
Sani Konukogly Medical Center
Turkey
Gaziantep
Turkey
Gaziantep
D. V. Fetser
Областная клиническая больница
Russian Federation
Russian Federation
Yu. N. Belenkov
M.V. Lomonosov Moscow State University
Russian Federation
Russian Federation
Moscow
References
1. Оганов Р.Г., Масленникова Г.Я. Профилактика сердечнососудистых заболеваний – реальный путь улучшения демографической ситуации в России. Кардиология 2007;47(1): 4-7.
2. Colombo A, Iakovou I. Ten years of advancements in interventional cardiology. J Endovasc Ther 2004; 11(Suppl 2): II10-8.
3. Беленков Ю.Н., Самко А.Н., Батыралиев Т.А., Першуков И.В. Коронарная ангиопластика: взгляд через 30 лет. Кардиология 2007; 9: 4-14.
4. Iakovou I, Sangiorgi GM, Stankovic G, et al. Effectiveness of sirolimus-eluting stent implantation for treatment of in-stent restenosis after brachytherapy failure. Am J Cardiol 2004; 94: 351-4.
5. Cohen DJ, Bakhai A, Shi C, et al. Cost-effectiveness of sirolimuseluting stents for treatment of complex coronary stenoses: results from the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients with De Novo Native Coronary Artery Lesions (SIRIUS) trial. Circulation 2004; 110: 508-14.
6. Colombo A, Iakovou I. Drug-eluting stents: the new gold standard for percutaneous coronary revascularisation. Eur Heart J 2004; 25: 895-7.
7. Batyraliev T, Avsar O. Coronary in-stent restenosis and drugeluting stents. The Tur J Inv Cardiol 2007; 11(4): 163-9.
8. Iakovou I, Ge L, Michev I, et al. Clinical and angiographic outcome after sirolimus-eluting stent implantation in aortoostial lesions. JACC 2004; 44: 967-71.
9. Moses JW, Leon MB, Popma JJ, et al, Kuntz RE, SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003; 349: 1315-23.
10. Yamashita T, Nishida T, Adamian MG, et al. Bifurcation lesions: two stents versus one stent – immediate and follow-up results. JACC 2000; 35: 1145-51.
11. Hoye A, Lemos PA, Aoki J, et al. Restenosis rates following bifurcation stenting with sirolimus-eluting stents for de novo narrowings. Am J Cardiol 2004; 94(1): 115-8.
12. Anzuini A, Briguori C, Rosanio S, et al. Immediate and long-term clinical and angiographic results from Wiktor stent treatment for true bifurcation narrowings. Am J Cardiol 2001; 88: 1246-50.
13. Al Suwaidi J, Berger PB, Rihal CS, et al. Immediate and long-term outcome of intracoronary stent implantation for true bifurcation lesions. JACC 2000; 35: 929-36.
14. Lemos PA, Serruys PW, van Domburg RT, et al. Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the real world: The rapamycin-eluting stent evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry. Circulation 2004; 109(2): 190-5.
15. Pan M, Suarez de Lezo J, Medina A, et al. Simple and complex stent strategies for bifurcated coronary arterial stenosis involving the side branch origin. Am J Cardiol 1999; 83: 1320-5.
16. Chevalier B, Glatt B, Royer T, Guyon P. Placement of coronary stents in bifurcation lesions by the “culotte” technique. Am J Cardiol 1998; 82: 943-9.
17. Colombo A, Moses JW, Morice MC, et al. Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions. Circulation 2004; 109: 1244-9.
18. Jamgyrchiev S, Fetcer DV, Pershukov IV, et al. Clinical impact of drug-eluting coronary stents. The Turkish Journal of Invasive Cardiology 2006; 10(4): 166-72.
19. Iakovou I, Ge L, Colombo A. Contemporary stent treatment of coronary bifurcations. JACC 2005; 46: 1446-55.
20. Ozgul S, Batyraliev T, Sercelik A, et al. The use of drug-eluting stents in single and multivessel disease: Results from our centre experience. The Tur J Inv Cardiol 2005; 9(1): 1-12.
21. Fort S, Lazzam C, Schwartz L. Coronary ‘Y’ stenting: a technique for angioplasty of bifurcation stenoses. Can J Cardiol 1996; 12: 678-82.
22. Kobayashi Y, Colombo A, Akiyama T, et al. Modifed «T» stenting: a technique for kissing stents in bifurcational coronary lesion. Cath Cardiovasc Diagn 1998; 43: 323-6.
23. Carrie D, Karouny E, Chouairi S, Puel J. “T”-shaped stent placement: a technique for the treatment of dissected bifurcation lesions. Cath Cardiovasc Diagn 1996; 37: 311-3.
24. Pan M, Suarez de Lezo J, Medina A, et al. A stepwise strategy for the stent treatment of bifurcated coronary lesions. Cath Cardiovasc Interv 2002; 55: 50-7.
25. Ormiston JA, Webster MW, Ruygrok PN, Stewart JT, White HD, Scott DS. Stent deformation following simulated side-branch dilatation: a comparison of five stent designs. Cath Cardiovasc Interv 1999; 47: 258-64.
26. Colombo A, Stankovic G, Orlic D, et al. Modifed T-stenting technique with crushing for bifurcation lesions: immediate results and 30-day outcome. Cath Cardiovasc Interv 2003; 60: 145-51.
27. Colombo A. Bifurcational lesions and the “crush” technique: understanding why it works and why it doesn’t – a kiss is not just a kiss. Cath Cardiovasc Interv 2004;63:337–8.
28. Schampaert E, Fort S, Adelman AG, Schwartz L. The V-stent: a novel technique for coronary bifurcation stenting. Cath Cardiovasc Diagn 1996; 39: 320-6.
29. Colombo A, Gaglione A, Nakamura S, Finci L. “Kissing” stents for bifurcational coronary lesion. Cath Cardiovasc Diagn 1993; 30: 327-30.
30. Ge L, Airoldi F, Iakovou I, et al. Clinical and angiographic outcome following implantation of drug-eluting stents in bifurcation lesions with the crush stent technique: importance of final kissing balloon post-dilatation. JACC 2005; 46: 613-20.
31. Ge L, Tsagalou E, Iakovou I, et al. In-hospital and nine-month outcome of treatment of coronary bifurcational lesions with sirolimus-eluting stent. Am J Cardiol 2005;95:75760.
32. Ormiston JA, Currie E, Webster MW, et al. Drug-eluting stents for coronary bifurcations: Insights into the crush technique. Cath Cardiovasc Interv 2004; 63: 332-6.
33. Sianos G, Vaina S, Hoya A, Serruys PW. Bifurcation stenting with drug-eluting stents: illustration of the crush technique. Cath Cardiovasc Interv 2006; 67(6): 839-45.
34. Kim YH, Park SW, Hong MK, et al. Comparison of simple and complex stenting techniques in the treatment of unprotected left main coronary artery bifurcation stenosis. Am J Cardiol 2006; 97(11): 1597-601. Epub 2006 Apr 7.
35. Collins N, Dzavik V. A modified balloon crush approach improves side branch access and side branch stent apposition during crush stenting of coronary bifurcation lesions. Cath Cardiovasc Interv 2006; 68(3): 365-71.
36. Sharma SK, Kini AS. Coronary bifurcation lesions. Cardiol Clin 2006; 24(2): 233-46, vi.
37. Costa RA, Moussa ID. Percutaneous treatment of coronary bifurcation lesions in the era of drug-eluting stents. Minerva Cardioangiol 2006; 54(5): 577-89.
38. Батыралиев Т.А., Фетцер Д.В., Преображенский Д.В., Сидоренко Б.А. Проблема осложнений при чрескожных коронарных вмешательствах. Часть I. Характер и частота осложнений. Кардиология 2008; 48(1): 81-7.
39. Lagerqvist B, James SK, Stenestrand U, et al. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med 2007; 356: 1009-19.
40. Nakamura S, Hall P, Maiello L, Colombo A. Techniques for Palmaz-Schatz stent deployment in lesions with a large side branch. Cath Cardiovasc Diagn 1995; 34: 353-61.
41. Alberti A, Missiroli B, Nannini C. ‘‘Skirt’’ technique for coronary artery bifurcation stenting. J Invasiv Cardiol 2000; 12: 633-6.
42. Hoye A, Iakovou I, Ge L, et al. Long-term outcomes after stenting of bifurcation lesions with the ‘‘crush’’ technique: predictors of an adverse outcome. JACC 2006; 47: 1949-58.
43. Carlson TA, Guarneri EM, Stevens KM, et al. ‘‘T-stenting’’: The answer to bifurcation lesions? Circulation 1996; 94: I86-7.
44. Karvouni E, Di Mario C, Nishida T, et al. Directional atherectomy prior to stenting in bifurcation lesions: a matched comparison study with stenting alone. Cath Cardiovasc Interv 2001; 53: 12-20.
45. Batyraliev T, Konukoglu O, Vural A, Demirbas O. Three angle bifurcation angioplasty and stenting. The Turk J Invasiv Cardiol 2006; 10(4): 180-3.
46. Khoja A, Ozbek C, Bay W, Heisel A. Trouser-like stenting: a new technique for bifurcation lesions. Cath Cardiovasc Diagn 1997; 41: 192-6; discussion 197-9.
47. Spokojny AM, Sanborn TM. The bifurcation lesion. In: Ellis SG, Holmes DR Jr., editors. Strategic Approaches in Coronary Intervention. Baltimore, MD: Williams and Wilkins, 1996; 288.
48. Lefevre T, Louvard Y, Morice MC, et al. Stenting of bifurcation lesions: classifcation, treatments, and results. Cath Cardiovasc Interv 2000; 49: 274-83.
Review
For citations:
Batyraliev T.A., Fetser D.V., Belenkov Yu.N. New TABAs technique in coronary bifurcation stenosis treatment. Cardiovascular Therapy and Prevention. 2009;8(7):108-113. (In Russ.)
Views:
498
Email this article 
